Display options
Cite
Palamaner Subash Shantha G, Kumar AA, Sethi M, et al. Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis. PeerJ. 2015;3:e835doi: 10.7717/peerj.835.
Palamaner Subash Shantha, G., Kumar, A. A., Sethi, M., Khanna, R. C., & Pancholy, S. B. (2015). Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis. PeerJ, 3e835. https://doi.org/10.7717/peerj.835
Palamaner Subash Shantha, Ghanshyam, et al. "Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis." PeerJ vol. 3 (2015): e835. doi: https://doi.org/10.7717/peerj.835
Palamaner Subash Shantha G, Kumar AA, Sethi M, Khanna RC, Pancholy SB. Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis. PeerJ. 2015 Mar 10;3:e835. doi: 10.7717/peerj.835. eCollection 2015. PMID: 25780780; PMCID: PMC4359121.
Copy Download .nbib Format: NLM
Share it on

PeerJ. 2015 Mar 10;3:e835. doi: 10.7717/peerj.835. eCollection 2015.

Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis.

PeerJ

Ghanshyam Palamaner Subash Shantha, Anita Ashok Kumar, Mansha Sethi, Rohit C Khanna, Samir Bipin Pancholy

Affiliations

  1. The Wright Center for Graduate Medical Education , Scranton, PA , USA ; The Johns Hopkins University, Bloomberg School of Public Health , Baltimore, MD , USA.
  2. Temple University School of Medicine , Philadelphia, PA , USA.
  3. Allen Foster Research Centre for Community Eye Health, International Centre for Advancement of Rural Eye Care, L V Prasad Eye Institute , Hyderabad , India.
  4. Department of Medicine, The Commonwealth Medical College , Scranton, PA , USA.

PMID: 25780780 PMCID: PMC4359121 DOI: 10.7717/peerj.835

Abstract

Background. Low molecular weight heparin (LMWH) is an effective anti-coagulant for thrombotic events. However, due to its predominant renal clearance, there are concerns that it might be associated with increased bleeding in patients with renal disease. Objectives. We systematically evaluated the efficacy and safety of LMWH compared to unfractionated heparin (UH) in end stage renal disease (ESRD) patients. Search Methods. Pubmed, Embase and cochrane central were searched for eligible citations. Selection Criteria. Randomized controlled trials, comparing LMWH and UH, involving adult (age > 18 years), ESRD patients receiving outpatient, chronic, intermittent hemodialysis were included. Data Collection and Analysis. Two independent reviewers performed independent data abstraction. I2 statistic was used to assess heterogeneity. Random effects model was used for meta-analysis. Results. Nineteen studies were included for systematic review and 4 were included for meta-analysis. There were no significant differences between LMWH and UFH for extracorporeal circuit thrombosis [risk ratio: 1 (95% CI [0.62-1.62])] and bleeding complications [risk ratio: 1.16 (95% CI [0.62-2.15])]. Conclusions. LMWH is as safe and effective as UFH. Considering the poor quality of studies included for the review, larger well conducted RCTs are required before conclusions can be drawn.

Keywords: Hemodialysis; Heparin; Meta-analysis; Thromboprophylaxis

References

  1. Am J Kidney Dis. 2006 May;47(5 Suppl 3):S11-145 - PubMed
  2. Kidney Int. 1996 Mar;49(3):806-13 - PubMed
  3. Nephrol Dial Transplant. 2007 Jun;22(6):1690-6 - PubMed
  4. Nephrol Dial Transplant. 2004 Jun;19(6):1559-63 - PubMed
  5. Artif Organs. 1998 Jul;22(7):614-7 - PubMed
  6. Artif Organs. 2001 Jul;25(7):591-5 - PubMed
  7. Nephrol Dial Transplant. 2003 Jul;18(7):1376-82 - PubMed
  8. Ren Fail. 2006;28(8):723-7 - PubMed
  9. Nephrol Dial Transplant. 2006 Jan;21(1):153-9 - PubMed
  10. JAMA. 2003 Jan 1;289(1):76-9 - PubMed
  11. Clin Appl Thromb Hemost. 2009 Feb;15(1):84-91 - PubMed
  12. BMC Nephrol. 2010 Dec 06;11:33 - PubMed
  13. Haemostasis. 1986;16 Suppl 2:59-68 - PubMed
  14. ASAIO Trans. 1991 Jul-Sep;37(3):M459-61 - PubMed
  15. Cytokine. 2007 Nov;40(2):98-104 - PubMed
  16. Blood Coagul Fibrinolysis. 2011 Oct;22(7):565-70 - PubMed
  17. Nephrol Dial Transplant. 1990;5(2):135-40 - PubMed
  18. Thromb Haemost. 1991 Sep 2;66(3):277-82 - PubMed
  19. Semin Thromb Hemost. 1999;25 Suppl 3:5-16 - PubMed
  20. Am Heart J. 2003 Jul;146(1):33-41 - PubMed
  21. Am J Kidney Dis. 2009 Feb;53(2):218-28 - PubMed
  22. Am J Kidney Dis. 2002 Nov;40(5):990-5 - PubMed
  23. Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S30-7 - PubMed
  24. Di Yi Jun Yi Da Xue Xue Bao. 2002 Oct;22(10):942-3 - PubMed
  25. Nephron. 2002;92(3):589-600 - PubMed
  26. Health Aff (Millwood). 2003 Jan-Jun;Suppl Web Exclusives:W3-219-26 - PubMed
  27. Am J Kidney Dis. 2001 Nov;38(5):979-87 - PubMed
  28. Nephrol Dial Transplant. 1986;1(3):179-87 - PubMed
  29. J Am Soc Nephrol. 2004 Dec;15(12):3192-206 - PubMed
  30. Pharmacotherapy. 2000 Jul;20(7):771-5 - PubMed
  31. Thromb Res. 2009 Feb;123(4):631-6 - PubMed
  32. Thromb Haemost. 2008 May;99(5):807-18 - PubMed
  33. Nephrol Dial Transplant. 1999 Nov;14(11):2698-703 - PubMed
  34. Clin Nephrol. 1989 Dec;32(6):290-6 - PubMed
  35. Kidney Int. 1988 Apr;33(4):890-6 - PubMed
  36. JAMA. 2010 Jan 20;303(3):235-41 - PubMed
  37. Am J Nephrol. 2002 Jan-Feb;22(1):58-66 - PubMed
  38. Nephrol Dial Transplant. 1995;10(2):217-22 - PubMed
  39. Int Angiol. 2006 Jun;25(2):101-61 - PubMed
  40. Am J Nephrol. 1997;17(2):153-7 - PubMed
  41. Ann Intern Med. 1999 May 18;130(10):800-9 - PubMed

Publication Types